$3 million awarded to five antimicrobial resistance-related projects
CUREator by Brandon BioCatalyst, a biotech incubator, has announced the allocation of $3 million to five life sciences projects through its third round. The projects are part of the Minimising Antimicrobial Resistance (AMR) stream of CUREator, which was established in 2021. and sponsors projects ranging from discovery to clinical development stages. AMR is a growing…